Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,171) with videos related to
Page
of 118
Sort By:
Annals of Emergency Medicine
|
May 14, 2018
Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial
Wesley H Self, Matthew W Semler, Rinaldo Bellomo, et al.
British Journal of Cancer
|
December 10, 2021
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Jeffrey G Supko, et al.
ESC Heart Failure
|
May 15, 2020
Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failure
Arzu Kalayci, W Frank Peacock, John T Nagurney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.
The New England Journal of Medicine
|
September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancer
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Perioperative Medicine (London, England)
|
April 28, 2020
Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance
Greg S Martin, David A Kaufman, Paul E Marik, et al.
Science (New York, N.Y.)
|
July 12, 1974
Mercury: results on mass, radius, ionosphere, and atmosphere from mariner 10 dual-frequency radio signals
H T Howard, G L Tyler, P B Esposito, et al.
Blood
|
March 3, 2012
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
John P Leonard, Ann S LaCasce, Mitchell R Smith, et al.
Cancer Discovery
|
March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib
Nikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2012
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer
Charles M Rudin, Christine L Hann, Edward B Garon, et al.
Page
of 118
Search research articles
Search
Showing results (1031-1040 of 1,171) with videos related to
Sort By:
Page
of 118
Annals of Emergency Medicine
|
May 14, 2018
Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial
Wesley H Self, Matthew W Semler, Rinaldo Bellomo, et al.
British Journal of Cancer
|
December 10, 2021
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Jeffrey G Supko, et al.
ESC Heart Failure
|
May 15, 2020
Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failure
Arzu Kalayci, W Frank Peacock, John T Nagurney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.
The New England Journal of Medicine
|
September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancer
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Perioperative Medicine (London, England)
|
April 28, 2020
Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance
Greg S Martin, David A Kaufman, Paul E Marik, et al.
Science (New York, N.Y.)
|
July 12, 1974
Mercury: results on mass, radius, ionosphere, and atmosphere from mariner 10 dual-frequency radio signals
H T Howard, G L Tyler, P B Esposito, et al.
Blood
|
March 3, 2012
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
John P Leonard, Ann S LaCasce, Mitchell R Smith, et al.
Cancer Discovery
|
March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib
Nikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2012
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer
Charles M Rudin, Christine L Hann, Edward B Garon, et al.
Page
of 118